Gland Pharma Ltd.

₹1751.6

Gland Pharma Ltd.

Add Alert
Add Watchlist

₹1751.6

₹1751.6

16.7 (0.96%) - 6 Dec 2025 04:25 PM

About Company

Gland Pharma Limited is focused on meeting diverse injectables needs with a stable supply of affordable and high quality products. It has established a portfolio of injectable products across various therapeutic areas and delivery systems. It is present in sterile injectables, oncology and ophthalmics, and focus on complex injectables, NCE-1s, First-to-File products and 505(b)(2) filings. Its delivery systems include liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops. It is expanding its development and manufacturing capabilities in complex injectables such as peptides, long-acting injectables, suspensions and hormonal products as well as new delivery systems such as pens and cartridges.

Market Cap. ₹ 31,926 Cr.
52 Week - High/Low ₹ 2,131/1,278
P/E Ratio 28.09
P/B Ratio 3.27
Enterprise Value ₹ 29,615 Cr.
ROE % 11.62
RSI Value 46.71
EMA 50 1936.59
EMA 200 1800.71
Market Cap. ₹ 31,926 Cr.
52 Week - High/Low ₹ 2,131/1,278
P/E Ratio 41.42
P/B Ratio 3.49
Enterprise Value ₹ 29,806 Cr.
ROE % 7.82
RSI Value 46.71
EMA 50 1936.59
EMA 200 1800.71

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.